Literature DB >> 9315994

Gabapentin abuse in a cocaine user: implications for treatment?

J S Markowitz, R Finkenbine, H Myrick, L King, W H Carson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9315994     DOI： 10.1097/00004714-199710000-00012

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  13 in total

1.  Psychiatric Uses of Newer Anticonvulsants.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 2.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 3.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

4.  Abuse of combinations of gabapentin and quetiapine.

Authors:  Roy R Reeves; Randy S Burke
Journal:  Prim Care Companion CNS Disord       Date:  2014-09-11

5.  An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user.

Authors:  Mance E Buttram; Steven P Kurtz; Theodore J Cicero; Jennifer R Havens
Journal:  Drug Alcohol Depend       Date:  2019-09-13       Impact factor: 4.492

6.  Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.

Authors:  Xiao-Qing Peng; Xia Li; Jie Li; P Veeraraghavan Ramachandran; Pravin D Gagare; Debarshi Pratihar; Charles R Ashby; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

Review 7.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

8.  A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors:  Stefania Chiappini; Fabrizio Schifano
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

9.  Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.

Authors:  Nathan J Pauly; Chris Delcher; Svetla Slavova; Eric Lindahl; Jeff Talbert; Patricia R Freeman
Journal:  J Manag Care Spec Pharm       Date:  2020-03

10.  Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.

Authors:  Alyssa M Peckham; Kathleen A Fairman; David A Sclar
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.